PT-523

· Spectrum Pharmaceuticals, Inc

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for PT-523, covering 2013-12-04 to 2014-03-31. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of PT-523 in Cancer Patients to Treat Solid Tumors Including a Preliminary Assessment of Effectiveness [Phase 1]

See pricing